Simon Bowler

2.9k total citations
60 papers, 1.4k citations indexed

About

Simon Bowler is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Simon Bowler has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 22 papers in Epidemiology and 18 papers in Physiology. Recurrent topics in Simon Bowler's work include Cystic Fibrosis Research Advances (13 papers), Influenza Virus Research Studies (12 papers) and Asthma and respiratory diseases (12 papers). Simon Bowler is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Influenza Virus Research Studies (12 papers) and Asthma and respiratory diseases (12 papers). Simon Bowler collaborates with scholars based in Australia, United Kingdom and United States. Simon Bowler's co-authors include Charles Mitchell, Sheree Smith, David J. Serisier, Amanda Green, Michael A. McGuckin, Rohan Lourie, Megan Martin, Sanmarié Schlebusch, Peter Dash and Ian A. Shiels and has published in prestigious journals such as JAMA, Physical review. B, Condensed matter and PLoS ONE.

In The Last Decade

Simon Bowler

57 papers receiving 1.4k citations

Peers

Countries citing papers authored by Simon Bowler

Since Specialization

Citations

This map shows the geographic impact of Simon Bowler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Bowler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Bowler more than expected).

Fields of papers citing papers by Simon Bowler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Bowler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Bowler. The network helps show where Simon Bowler may publish in the future.

Co-authorship network of co-authors of Simon Bowler

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Bowler. A scholar is included among the top collaborators of Simon Bowler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Bowler. Simon Bowler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brensocatib: An Anti-neutrophil Elastase Drug With Potential in the Management of Bronchiectasis 2022 ·Simon Bowler	2
2	Piperacillin–tazobactam‐induced haemolytic anaemia after multiple courses of therapy 2021 ·Internal Medicine Journal ·(unknown), Simon Bowler	0
3	PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa 2018 ·PLoS ONE ·Lucy Burr, Geraint B. Rogers, Alice C.–H. Chen, Steven Taylor, Simon Bowler, (unknown), Megan Martin, Sumaira Z. Hasnain, Michael A. McGuckin	3
4	Impact of Opioid Therapy on Sleep and Respiratory Patterns in Adults With Advanced Cancer Receiving Palliative Care 2017 ·Journal of Pain and Symptom Management ·Phillip Good, Ross Pinkerton, Simon Bowler, Justin M. Craig, Janet Hardy	12
5	Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non–Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial 2016 ·Annals of the American Thoracic Society ·Lucy Burr, Geraint B. Rogers, Alice C.–H. Chen, Brett R. Hamilton, (unknown), Steven Taylor, Deon J. Venter, Simon Bowler, (unknown), Michael A. McGuckin	26
6	Adult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation 2015 ·PLoS ONE ·Alice C.–H. Chen, Megan Martin, Rohan Lourie, Geraint B. Rogers, Lucy Burr, Sumaira Z. Hasnain, Simon Bowler, Michael A. McGuckin, David J. Serisier	17
7	Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects 2013 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Miguel Marcos, Lucy Burr, (unknown), Rohan Lourie, Simon Bowler, Michael A. McGuckin, David J. Serisier	3
8	Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis…without Patient Blinding 2012 ·American Journal of Respiratory and Critical Care Medicine ·David J. Serisier, Simon Bowler	3
9	Influenza A/H1N1_09: Australia and New Zealand's Winter of Discontent 2010 ·American Journal of Respiratory and Critical Care Medicine ·Tom Kotsimbos, Grant Waterer, Christine Jenkins, Paul Kelly, Allen Cheng, Robert J. Hancox, Mark Holmes, Richard Wood‐Baker, Simon Bowler, Louis Irving, Philip Thompson	33
10	Standardversuspatient-centred asthma education in the emergency department: a randomised study 2008 ·European Respiratory Journal ·Sheree Smith, Charles Mitchell, Simon Bowler	24
11	Patient-Centered Education: Applying Learner-Centered Concepts to Asthma Education 2007 ·Journal of Asthma ·Sheree Smith, Charles Mitchell, Simon Bowler	18
12	Dailyversusweekly azithromycin in cystic fibrosis patients 2007 ·European Respiratory Journal ·J. G. McCormack, Scott C. Bell, (unknown), K. Walmsley, (unknown), Claire Wainwright, David J. Serisier, Michael T. Harris, Simon Bowler	37
13	Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults 2005 ·Internal Medicine Journal ·(unknown), Simon Bowler, (unknown), Charles Mitchell	28
14	A pilot study comparing substitutable care at home with usual hospital care acute Chronic Obstructive Pulmonary Disease. Final report to National Demonstration Hospital Program 2001 ·Physical review. B, Condensed matter ·Simon Bowler, David J. Serisier, (unknown), Peter O’Rourke, Caroline Nicholson, (unknown), Claire Jackson	1
15	Managing meningococcal disease case clusters: art or science? 1999 ·Journal of Epidemiology & Community Health ·(unknown), Simon Bowler, (unknown), Martyn Regan	5
16	The Effects of Salbutamol, Beclomethasone, and Dexamethasone on Fibronectin Expression by Cultured Airway Smooth Muscle Cells 1999 ·Inflammation ·Ian A. Shiels, Simon Bowler, Stephen M. Taylor	51
17	Successful Treatment of Severe Cytomegalovirus Infection with Ganciclovir in an Immunocompetent Host 1998 ·Clinical Infectious Diseases ·J. G. McCormack, Simon Bowler, (unknown), Charles Steadman	20
18	Airway smooth muscle proliferation in asthma: The potential of vascular leakage to contribute to pathogenesis 1995 ·Medical Hypotheses ·Ian A. Shiels, Simon Bowler, Stephen M. Taylor	21
19	Bambuterol yields better effect/side effect ratio than terbutaline in elderly patients with CROAD; multicentre study Australia 1993 ·UWA Profiles and Research Repository (University of Western Australia) ·(unknown), Christine F. McDonald, Simon Bowler, Philip J. Thompson, Deborah Allen, Glenn Bowes, (unknown), Peter Frith, K Murree-Allen, (unknown), Nicholas A. Saunders	1
20	Heparin Inhibits the Immediate Response to Antigen in the Skin and Lungs of Allergic Subjects 1993 ·American Review of Respiratory Disease ·Simon Bowler, Sheree Smith, (unknown)	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact